Want to track KYNB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kyntra Bio, Inc. (KYNB) Statistics
Valuation metrics
Market Cap 29.63M
Enterprise value 11.52M
Trailing P/E (ttm) 0.17
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 3.93
Price/Book (mrq) -0.67
Enterprise Value/Revenue 1.55
Enterprise Value/EBITDA -0.21
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 9.21K
Average volume (90 days) 22.68K
Price summary
52-Week low 6.32
52-Week high 12.6
Beta -
50-Day moving average 7.03
200-Day moving average 7.51
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 17 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 21.99%
Operating margin -6.04%
Operational effectiveness
Return on assets 1.49%
Return on equity -2.34%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.84
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 40.43
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 21.56
Total debt (mrq) -
Total Debt/Equity (mrq) -0.44
Current ratio (mrq) 3.61%
Book value per share (mrq) -7.6
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
